Over the past five years, diabetes-focused medical device specialist DexCom ( DXCM -0.50%) has made meaningful progress on several fronts. The company launched new products in the continuous glucose ...

Folks who struggle to reduce their carb intake might be able to blame ancient DNA still lurking in humans, a new study ...

Biohacking is a DIY approach to achieving optimal health. The idea is that by testing and tracking your body’s personal ...

Report on how AI is redefining market landscape - The Global Biopolymers Market size is estimated to grow by USD 17.11 ...

There is a promising step forward to treat and possibly cure type one diabetes, which is good news for Louisiana, as our state leads the nation ...

The global market for diabetes care devices is forecast to reach US $16 billion by 2030 with a growing compound annual growth rate (CAGR) of 6.5% during the forecast period 2021-2030. In 2020, the ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved VYLOY™ (zolbetuximab-clzb) in combination ...

This valuable study addresses potential roles of the master regulator of X chromosome inactivation, the Xist long non-coding RNA, in autosomal gene regulation. Using data from mouse cells, the authors ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved VYLOYtm (zolbetuximab-clzb) in combination ...

Your 40s can be a transformative time, filled with new challenges and opportunities for personal growth. However, it’s also a ...

High-fiber foods, lean proteins, and certain vitamins and minerals are examples of natural appetite suppressants. It's ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...